Skip to Main Content


Skip Nav Destination

Abstract 394: Novel pan-PIM/pan-PI3K/mTOR inhibitors are highly active in preclinical models of pancreatic ductal adenocarcinoma

Cancer Res (2016) 76 (14_Supplement): 394.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Kyle Crassini
  • Yandong Shen
  • Michael O'Dwyer
  • Michael O'Neill
  • Richard Christopherson
  • Stephen Mulligan
  • O. Giles Best
British Journal of Haematology (2018) 182 (5): 654.
Close Modal

or Create an Account

Close Modal
Close Modal